Emergent BioSolutions (EBS) Shares Outstanding (Diluted Average) (2010 - 2026)

Emergent BioSolutions' Shares Outstanding (Diluted Average) history runs 13 years deep, the most recent figure standing at $56.5 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) fell 1.4% year-over-year to $56.5 million; the TTM figure through Mar 2026 stood at $56.5 million (down 1.4% YoY), while the FY2025 annual figure was $56.7 million, up 6.98% from the prior year.
• Shares Outstanding (Diluted Average) was $56.5 million for Q1 2026 at Emergent BioSolutions, roughly flat from $56.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $57.3 million in Q1 2025 to a low of $50.1 million in Q4 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $53.1 million across 5 years, with a median of $52.2 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Diluted Average) decreased 7.39% in 2022, then increased 9.77% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $50.1 million in 2022, then gained by 2.2% to $51.2 million in 2023, then grew by 3.52% to $53.0 million in 2024, then climbed by 6.98% to $56.7 million in 2025, then declined by 0.35% to $56.5 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $56.5 million (Q1 2026), $56.7 million (Q4 2025), and $56.5 million (Q3 2025), per Business Quant data.